Venetoclax After TKI to Target Persisting Stem Cells in CML

Clinical trial NCT05701215 · COMPLETED

Trial details

NCT number: NCT05701215
Sponsor: Thomas Ernst, PD Dr. med.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2023-08-31
Primary completion: 2026-05-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.